279 related articles for article (PubMed ID: 34360767)
1. HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.
Forlani G; Shallak M; Accolla RS; Romanelli MG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360767
[TBL] [Abstract][Full Text] [Related]
2. HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role.
Fochi S; Mutascio S; Bertazzoni U; Zipeto D; Romanelli MG
Front Microbiol; 2018; 9():285. PubMed ID: 29515558
[TBL] [Abstract][Full Text] [Related]
3. From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis.
Pérès E; Bagdassarian E; This S; Villaudy J; Rigal D; Gazzolo L; Duc Dodon M
Viruses; 2015 Dec; 7(12):6371-86. PubMed ID: 26690200
[TBL] [Abstract][Full Text] [Related]
4. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma.
Yamagishi M; Kubokawa M; Kuze Y; Suzuki A; Yokomizo A; Kobayashi S; Nakashima M; Makiyama J; Iwanaga M; Fukuda T; Watanabe T; Suzuki Y; Uchimaru K
Nat Commun; 2021 Aug; 12(1):4821. PubMed ID: 34376672
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread.
Kalinichenko S; Komkov D; Mazurov D
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062355
[TBL] [Abstract][Full Text] [Related]
6. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
[TBL] [Abstract][Full Text] [Related]
7. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer.
Pietropaolo V; Prezioso C; Moens U
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361112
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 infection in acute t- lymphocytic leukemia/lymphoma.
Barouqa M; Gil MR; Sekhri R; Popoola M; Ding J; Wang Y
Autops Case Rep; 2021; 11():e2021307. PubMed ID: 34458175
[TBL] [Abstract][Full Text] [Related]
9. Human inborn errors of immunity to oncogenic viruses.
Béziat V; Jouanguy E
Curr Opin Immunol; 2021 Oct; 72():277-285. PubMed ID: 34364035
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 persistent infection and ATLL oncogenesis.
Zuo X; Zhou R; Yang S; Ma G
J Med Virol; 2023 Jan; 95(1):e28424. PubMed ID: 36546414
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system.
Tan BJY; Sugata K; Ono M; Satou Y
Front Immunol; 2022; 13():991928. PubMed ID: 36300109
[TBL] [Abstract][Full Text] [Related]
12. Tuning Rex rules HTLV-1 pathogenesis.
Nakano K; Watanabe T
Front Immunol; 2022; 13():959962. PubMed ID: 36189216
[TBL] [Abstract][Full Text] [Related]
13. Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.
El Hajj H; Bazarbachi A
Front Immunol; 2022; 13():957535. PubMed ID: 35935975
[TBL] [Abstract][Full Text] [Related]
14. Regulation of HTLV-1 transformation.
Ernzen KJ; Panfil AR
Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35169839
[TBL] [Abstract][Full Text] [Related]
15. The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape.
Vandermeulen C; O'Grady T; Wayet J; Galvan B; Maseko S; Cherkaoui M; Desbuleux A; Coppin G; Olivet J; Ben Ameur L; Kataoka K; Ogawa S; Hermine O; Marcais A; Thiry M; Mortreux F; Calderwood MA; Van Weyenbergh J; Peloponese JM; Charloteaux B; Van den Broeke A; Hill DE; Vidal M; Dequiedt F; Twizere JC
PLoS Pathog; 2021 Sep; 17(9):e1009919. PubMed ID: 34543356
[TBL] [Abstract][Full Text] [Related]
16. Identification of joint gene players implicated in the pathogenesis of HTLV-1 and BLV through a comprehensive system biology analysis.
Ashrafi F; Ghezeldasht SA; Ghobadi MZ
Microb Pathog; 2021 Nov; 160():105153. PubMed ID: 34419613
[TBL] [Abstract][Full Text] [Related]
17. An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines.
Lucchese G; Jahantigh HR; De Benedictis L; Lovreglio P; Stufano A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452327
[TBL] [Abstract][Full Text] [Related]
18. Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma.
Islam S; Espitia CM; Persky DO; Carew JS; Nawrocki ST
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372612
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion.
Mohanty S; Harhaj EW
Pathogens; 2023 May; 12(5):. PubMed ID: 37242405
[TBL] [Abstract][Full Text] [Related]
20. How Can We Prevent Mother-to-Child Transmission of HTLV-1?
Itabashi K; Miyazawa T; Uchimaru K
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
